Transcripts

Jade Biosciences (JBIO) earnings call transcripts

Earnings call transcripts for Jade Biosciences, Inc., with a summary, the guidance given, and what analysts pressed on.

Open JBIO in Gloom →
Jade Biosciences' chart, financials and news, free in your browser.Open JBIO in Gloom →
  • FY 2026 earnings call

    Management framed JAD301 as a convenience-led effort to build on clinically validated interferon-beta biology, while acknowledging its clinical profile remains unproven.

    Sep 30, 2026Positive0.55